// App-Quantinova.ai

17416 : Enalapril Therapy Improved Late Survival in Patients With Asymptomatic or Minimally Symptomatic Left Ventricular Systolic Dysfunction: A 24-Year Follow-up of SOLVD in Belgium

Researchers

Presenter

  • Sylvie A. Ahn

Principal Investigators

  • Hubert Pouleur

  • Michel F. Rousseau

Medical Centers

  • Univ of Louvain/Pfizer Inc, Brussels, Belgium

  • McMaster University, Hamilton, ON, Canada

  • University of Louvain, Brussels, Belgium

Locations

  • Canada

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Left ventricular dysfunction

  • Systolic dysfunction

  • Congestive heart failure

  • Arrhythmia

Biomarkers

  • N/A

Drug/Treatment

  • Enalapril maleate

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim